130 related articles for article (PubMed ID: 15778051)
1. Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A.
Jin M; Shimada T; Yokogawa K; Nomura M; Mizuhara Y; Furukawa H; Ishizaki J; Miyamoto K
Int J Pharm; 2005 Apr; 293(1-2):137-44. PubMed ID: 15778051
[TBL] [Abstract][Full Text] [Related]
2. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
[TBL] [Abstract][Full Text] [Related]
3. Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.
Sparreboom A; Verweij J; van der Burg ME; Loos WJ; Brouwer E; Viganò L; Locatelli A; de Vos AI; Nooter K; Stoter G; Gianni L
Clin Cancer Res; 1998 Aug; 4(8):1937-42. PubMed ID: 9717822
[TBL] [Abstract][Full Text] [Related]
4. Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.
Sparreboom A; van Zuylen L; Brouwer E; Loos WJ; de Bruijn P; Gelderblom H; Pillay M; Nooter K; Stoter G; Verweij J
Cancer Res; 1999 Apr; 59(7):1454-7. PubMed ID: 10197613
[TBL] [Abstract][Full Text] [Related]
5. Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.
Yokogawa K; Jin M; Furui N; Yamazaki M; Yoshihara H; Nomura M; Furukawa H; Ishizaki J; Fushida S; Miwa K; Miyamoto K
J Pharm Pharmacol; 2004 May; 56(5):629-34. PubMed ID: 15142340
[TBL] [Abstract][Full Text] [Related]
6. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
[TBL] [Abstract][Full Text] [Related]
7. Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.
Gelderblom H; Verweij J; van Zomeren DM; Buijs D; Ouwens L; Nooter K; Stoter G; Sparreboom A
Clin Cancer Res; 2002 Apr; 8(4):1237-41. PubMed ID: 11948138
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.
Tanaka C; Kawai R; Rowland M
Drug Metab Dispos; 2000 May; 28(5):582-9. PubMed ID: 10772639
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats.
Taljanski W; Pierzynowski SG; Lundin PD; Westrom BR; Eirefelt S; Podlesny J; Dahlback M; Siwinska-Golebiowska H; Karlsson BW
Drug Metab Dispos; 1997 Aug; 25(8):917-20. PubMed ID: 9280398
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induced by Cremophor EL is not accompanied by changes in NF-kappaB activation or iNOS expression.
Gutiérrez MB; Miguel BS; Villares C; Gallego JG; Tuñón MJ
Toxicology; 2006 May; 222(1-2):125-31. PubMed ID: 16533553
[TBL] [Abstract][Full Text] [Related]
11. Linearized colorimetric assay for cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusions.
Brouwer E; Verweij J; Hauns B; Loos WJ; Nooter K; Mross K; Stoter G; Sparreboom A
Anal Biochem; 1998 Aug; 261(2):198-202. PubMed ID: 9716422
[TBL] [Abstract][Full Text] [Related]
12. Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients.
van Zuylen L; Gianni L; Verweij J; Mross K; Brouwer E; Loos WJ; Sparreboom A
Anticancer Drugs; 2000 Jun; 11(5):331-7. PubMed ID: 10912949
[TBL] [Abstract][Full Text] [Related]
13. Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics.
Fahr A; Holz M; Fricker G
Pharm Res; 1995 Aug; 12(8):1189-98. PubMed ID: 7494833
[TBL] [Abstract][Full Text] [Related]
14. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
[TBL] [Abstract][Full Text] [Related]
15. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K
Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156
[TBL] [Abstract][Full Text] [Related]
17. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats.
Molpeceres J; Chacón M; Aberturas MR; Guzmán M; Díez ML; Rodriguez-Puyol M
Pharmazie; 2001 Jan; 56(1):78-82. PubMed ID: 11210676
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
Shibata N; Shimakawa H; Minouchi T; Yamaji A
Biol Pharm Bull; 1993 Nov; 16(11):1130-5. PubMed ID: 8312870
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo studies of cyclosporin A-loaded microspheres based on copolymers of lactide and epsilon-caprolactone: comparison with conventional PLGA microspheres.
Li Y; Zhu KJ; Zhang JX; Jiang HL; Liu JH; Hao YL; Yasuda H; Ichimaru A; Yamamoto K
Int J Pharm; 2005 May; 295(1-2):67-76. PubMed ID: 15847992
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
